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S U M M A R Y
Background: HIV infection continues to pose a serious challenge to global health by predisposing patients
to opportunistic infections. A cross-sectional study was conducted from December 2012 to February
2013 to assess the enteric protozoan infection status among individuals living with HIV/AIDS in
Felegehiwot Referral Hospital, Bahir Dar, northwest Ethiopia.
Methods: Stool specimens from 399 HIV-positive individuals were examined for the presence of
trophozoites, cysts, and oocysts using direct wet mount, formol–ether sedimentation and modiﬁed
Ziehl–Neelsen techniques. In addition, CD4+ T-cell counts were measured to evaluate the immune status
of the study subjects.
Results: An overall prevalence of 30.6% enteric protozoan infections was recorded. Pre-ART
(antiretroviral treatment) individuals were more infected than patients on ART, although this was
not statistically signiﬁcant (p > 0.05). The highest prevalence of enteric protozoan infection was due to
Entamoeba histolytica/E. dispar (19.3%), followed by Cryptosporidium spp (5.8%), Giardia lamblia (4.3%),
and Isospora belli (1.3%). A CD4+ T-cell count of <200 cells/ml and status of being diarrhoeic were
signiﬁcantly associated with the overall prevalence of enteric protozoan infection.
Conclusions: A relatively high prevalence of enteric protozoan infection was observed among individuals
living with HIV/AIDS. Routine stool and CD4+ T-cell examinations should be conducted to monitor the
status of HIV/AIDS patients.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/4.0/).
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Opportunistic and non-opportunistic intestinal parasitic infec-
tions are commonly known for the manifestation and presentation
of various degrees of diarrhoea in immune-compromised individu-
als. Diarrhoea occurs in about 90% of individuals living with HIV/
AIDS in developing countries.1 The presence of opportunistic
protozoan parasites such as Cryptosporidium spp, Cyclospora
cayetanensis, Isospora belli, and Microsporidia spp have been
documented in individuals living with HIV/AIDS.2,3 In particular,
Cryptosporidium spp and I. belli are implicated in severe, persistent,
and life-threatening diarrhoea, especially in HIV-positive and AIDS
patients.4 Non-opportunistic parasites such as Entamoeba histolytica
and Giardia lamblia are also important parasites in diarrhoeal disease
that occur in individuals living with HIV/AIDS.5 The incidence and
prevalence of infection with a particular enteric protozoan parasite* Corresponding author. Tel.: +251 918 30 97 04.
E-mail address: endtg2002@yahoo.com (E. Nibret).
http://dx.doi.org/10.1016/j.ijid.2015.04.012
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/4.0/).in individuals living with HIV/AIDS is likely to depend upon the
endemicity of that particular parasite in the community. In general,
Cryptosporidium spp, I. belli, and E. histolytica have been reported as
the most frequently identiﬁed parasites, and these represent a
signiﬁcant cause of diarrhoea in the HIV/AIDS population.6,7
Since the introduction of antiretroviral therapy (ART) in Ethiopia,
the quality of life and survival of HIV-positive individuals have
improved.8 A considerable decline in mortality of adult AIDS
patients was shown to be related to the start of ART in Addis Ababa,
Ethiopia.9 Although there has been an improvement in the survival
of patients, parasitic infections pose a serious challenge with regard
to reducing the morbidity and mortality of these individuals.
A few studies have been carried out on the prevalence of enteric
protozoan infections among individuals living with HIV/AIDS in
relation to ART in Ethiopia.10–12 The current study was undertaken
to assess the prevalence of enteric protozoan infections in relation
to socio-demographic and clinical factors in individuals living
with HIV/AIDS at Felegehiwot Referral Hospital, Bahir Dar, in the
northwest of Ethiopia.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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2.1. Sampling procedure
A cross-sectional study was conducted to identify and
determine enteric protozoan infections among individuals living
with HIV/AIDS. Study subjects were HIV-positive individuals who
were ART-naı¨ve and those on ART, aged between 18 and 60 years.
Patients included in the on-ART group had been treated with ART
for at least 3 months. Participants were excluded from the study if
they were out of the age range, pregnant, or had been on ART for
less than 3 months.
A systematic random sampling method was used. Every other
subject called upon to attend a regular check-up was included in
the study until the required sample size was reached. Almost equal
numbers of samples were taken from each group: 199 study
subjects were pre-ART and the other 200 were on ART.
2.2. Stool examination
Study subjects were given labelled, leak-proof, clean sterile
plastic screw-cap containers to collect their stool samples. Samples
were collected from the participant on the day that the study
questionnaire was completed. Stool samples were evaluated by
direct microscopic examination, formol–ether concentration
technique, and modiﬁed Ziehl–Neelsen acid-fast method.13
2.3. Immunological assessment
Blood samples were collected in heparinated vacutainer tubes
(PLK2) for CD4+ T-cell count measurement; these were analyzed
using a fully automated ﬂuorescence activated cell sorting (FACS)
counter (Becton and Dickinson, Immunocytometry Systems, San
Jose, CA, USA) in the ART clinic of Felegehiwot Referral Hospital,
Bahir Dar, Ethiopia.
2.4. World Health Organization (WHO) clinical staging of HIV/AIDS
Study subjects were ﬁrst examined by a medical doctor and,
based on the clinical signs and symptoms stated in WHO guidelines,
they were classiﬁed into WHO clinical stages I, II, III, and IV.14
2.5. Questionnaire
A pre-structured questionnaire was used to collect socio-
demographic information such as age, sex, location of residence,
level of education, marital status, occupation and monthly income,
and knowledge, attitude, perception and practice related to the use
of antiretroviral (ARV) drugs of the study participants. Health
practices and behavioural habits with regard to health conditions
with a history of symptoms were recorded. Environmental
conditions such as the water supply, provision of a sanitation
system, swimming practices, and method of waste disposal were
also recorded.
2.6. Data analysis
Data were analyzed using SPSS software version 16 (SPSS Inc.,
Chicago, IL, USA). Values were considered signiﬁcant when the p-
value was less than 0.05 with the respective 95% conﬁdence
intervals.
2.7. Ethical considerations
The study was approved on November 8, 2012 by an ethics
committee consisting of ﬁve members from Bahir Dar University(record number RCS/869/2005), and permission was also obtained
from Felegehiwot Referral Hospital. Informed consent was
obtained from all participants before testing and commencing
the study. Subject conﬁdentiality and privacy were protected by
ensuring that no names appeared on any part of the report.
3. Results
3.1. Socio-demographic and general characteristics of the study
participants
A total of 399 individuals living with HIV/AIDS were recruited
into this study. Out of the 399 study subjects, 50.13% (n = 200) had
been on ART over different periods of time and were assigned to
the on-ART group and 49.87% (n = 199) were not on ART and were
assigned to the pre-ART group.
Female subjects outnumbered males: females 60.40% (n = 241)
and males 39.60% (n = 158). The mean age of the study participants
was 35  8.63 years, ranging from 18 to 60 years, with the majority of
the study population belonging to the age group 29–39 years (46.87%,
n = 187).
In terms of location of residence, the majority were urban
dwellers: 79.70% (n = 318) lived in urban areas and 20.30% (n = 81)
in rural areas.
The mean monthly household income of the total study group
was US$ 54.00  43.50, with a minimum income of US$ 5.30 and
maximum of US$ 325.80. Out of the total study participants, the
majority 39.1% (n = 156) of households earned between US$
26.90 and US$ 53.80 monthly and 31.3% (n = 125) earned less than
US$ 26.90 per month. Seventy-nine (19.8%) participants had a
monthly income between US$ 53.80 and US$ 107.50 and the
remaining 9.8% (n = 39) of study subjects earned more than US$
107.50 per month.
3.2. Prevalence of enteric protozoan infections based on socio-
demographic factors
Infection rates of 8.8% for E. histolytica/E. dispar, 3.5% for
Cryptosporidium spp, 2.8% for G. lamblia, and 0.25% for I. belli were
found (Table 1). Stool examinations revealed that 27.8% (44/158) of
males and 27.8% (67/241) of females were infected with the enteric
protozoan parasites. With regard to age, the infection rate
appeared to be higher within the age group of 29–39 years
(29.4%, 55/187) compared to the other age groups. In terms of
location of residence, 26.7% (85/318) of the urban residents and
32.1% (26/81) of the rural dwellers were infected with enteric
protozoan parasites.
Across occupational groups, the prevalence was 22.8% (13/57)
among the unemployed, 22.2% (14/63) among casual labourers,
30.7% (27/88) among government employees, 30.3% (37/122)
among the self-employed, and 40% (4/10) among students. Thirty-
six percent (8/22) of peasant farmers and 21.6% (8/37) of privately
employed study subjects had the infection.
3.3. Prevalence of enteric protozoan infections based on clinical status
Of the 399 persons examined for enteric protozoa, 122 were
found to be infected with at least one of the enteric protozoa
identiﬁed, with an overall prevalence of 30.6%. The results of the
stool sample analysis showed that the main enteric protozoa
parasites identiﬁed among the study participants in order of
frequency were E. histolytica/E. dispar, Cryptosporidium spp, G.
lamblia, and I. belli. The highest prevalence was due to E. histolytica/
E. dispar (19.3%, 77/399), followed by Cryptosporidium spp (5.8%,
23/399) and G. lamblia (4.3%, 17/399); the lowest infection rate was
due to I. belli (1.3%, 5/399) (Table 2).
Table 1
The prevalence of enteric protozoan infections according to sex, age, location of residence, and level of education; Felegehiwot Referral Hospital, Bahir Dar 2012–2013
Variables Non-infected Type of enteric protozoan infection (%) Total positivity
(N = 399)
EHI GLA CRY ISO
Sex Male 114 27 (6.8) 6 (1.5) 12 (3) 3 (0.75) 48 (12)
Female 174 50 (12.5) 11 (2.75) 11 (2.75) 2 (0.5) 74 (18.5)
Age, years 18–28 72 21 (5.3) 1 (0.25) 4 (1) 3 (0.75) 29 (7.3)
29–39 132 35 (8.8) 11 (2.75) 14 (3.5) 1 (0.25) 61 (15.3)
40–50 65 16 (4) 4 (1) 4 (1) 1 (0.25) 25 (6.3)
51–60 19 5 (1.3) 1 (0.25) 1 (0.25) 0 (0) 7 (1.75)
Residence Rural 55 13 (3.3) 8 (2) 8 (2) 2 (0.5) 31 (7.8)
Urban 233 64 (16) 9 (2.5) 15 (3.8) 3 (0.75) 91 (22.8)
Level of education No education 94 21 (5.3) 4 (1) 5 (1.3) 1 (0.25) 31 (7.8)
Informal 17 3 (0.75) 2 (0.5) 2 (0.5) 3 (0.75) 10 (2.5)
Primary 66 19 (4.8) 3 (0.75) 9 (2.3) 0 (0) 31 (7.8)
Secondary 77 22 (5.5) 6 (1.5) 6 (1.5) 0 (0) 34 (8.5)
Tertiary 34 12 (3) 2 (0.5) 1 (0.25) 1 (0.25) 16 (4)
EHI, Entamoeba histolytica/E. dispar; GLA, Giardia lamblia; CRY, Cryptosporidium spp; ISO, Isospora belli.
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83.6% (102/122). Mixed infection with E. histolytica/E. dispar and
Cryptosporidium spp was found in 4.1% (5/122). Infection with both
E. histolytica/E. dispar and G. lamblia was found in 1.6% (2/122), and
infection with E. histolytica/E. dispar and I. belli in 0.8% (1/122).
Triple infection with E. histolytica/E. dispar, G. lamblia, and
Cryptosporidium spp was found in 0.8%.
The overall prevalence of enteric protozoan infections in pre-
ART subjects was 35.7% (71/199); the prevalence of E. histolytica/
E. dispar, G. lamblia, Cryptosporidium spp, and I. belli in these
patients was 19.6% (39/199), 5.03% (10/199), 8.54% (17/199), and
2.51% (5/199), respectively. The most prevalent enteric protozoan
infections in pre-ART patients were E. histolytica/E. dispar and
Cryptosporidium spp.
With regard to the on-ART subjects, the overall prevalence of
infection was 25.5% (51/200), with 19% (38/200), 3.5% (7/200), and
3% (6/200) due to E. histolytica/E. dispar, G. lamblia, and
Cryptosporidium spp, respectively. I. belli was not identiﬁed in
any on-ART patient in this study.
Relatively similar numbers of cases of infection with E.
histolytica/E. dispar and G. lamblia were observed in the pre-ART
and on-ART subjects. However, high rates of infection with
cryptosporidiosis and isosporiasis were seen in the pre-ART
subjects. A statistically signiﬁcant difference was observed in
the prevalence of cryptosporidiosis and isosporiasis between pre-
ART and on-ART study participants (Table 2).
The overall infection rate with parasitic protozoa was higher in
pre-ART participants than in on-ART participants. However, there
was no signiﬁcant association (p > 0.05) between the overall
infection rate and ART status. Based on the diarrhoeal status, a
higher prevalence of infection was identiﬁed among diarrhoeic
patients than non-diarrhoeic ones. A signiﬁcant association
(p < 0.05) was observed between the prevalence of entericTable 2
Distribution of enteric protozoan parasites in pre-ART and on-ART study subjects; Fele
Enteric parasite ART status 
Pre-ART (n = 199) O
Entamoeba histolytica/E. dispar (n = 77) 39 (50.6%) 
Giardia lamblia (n = 17) 10 (58.8%) 
Cryptosporidium spp (n = 23) 17 (73.9%) 
Isospora belli (n = 5) 5 (100%) 
Total 71 (35.7%) 
Overall infection both in pre-and on-ART 1
ART, antiretroviral therapy.
a Statistically signiﬁcant, Chi-square test.protozoan infection and being diarrhoeic among study subjects.
With regard to the WHO clinical stage of the patients, most were in
stage III (49.1%, 196/399), followed by stage II (28.8%, 115/399),
stage I (19.3%, 77/399), and stage IV (2.8%, 11/399) (Table 3). The
presence of associated opportunistic infections was seen in only 28
(7.02%) HIV patients out of the total study subjects.
The effects of socio-demographic, clinical, and sanitation
factors on the prevalence of cryptosporidiosis and giardiasis
infection among individuals living with HIV/AIDS were assessed,
and these were found to be determinants of the occurrence of
these infections. There was a statistically signiﬁcant association
(p < 0.05) between the prevalence of cryptosporidiosis and ART
status, CD4+ T-cell status, diarrhoea, work status, and access to a
toilet. With regard to giardiasis, this was shown to be signiﬁcantly
associated with diarrhoea and residential location. Thus, the
results further revealed location of residence to be independently
associated (p < 0.05) with the prevalence of giardiasis (Table 5).
The enteric protozoan infection status with respect to the CD4+
T-cell count was variable among the study participants and there
was an association between CD4+ T-cell count and the opportu-
nistic coccidian parasite among patients on and not on ART. The
maximum parasitic infection was 50.7% (34/67) in patients with a
CD4+ T-cell count of <200 cells/ml, and was 25.4% (60/236) in
patients whose CD4+ T-cell count was between 200 and 500 cells/
ml and 17.7% (17/96) in patients whose CD4+ T-cell count was
>500 cells/ml. Infection with cryptosporidiosis and isosporiasis
was highly associated (p < 0.05) with a low CD4+ T-cell count
(<200 cells/ml) (Figure 1).
The CD4+ T-cell counts of the study participants ranged from as
low as 3 to 1274 cells/ml, with a median of 358 cells/ml and mean of
381.73  202.62 cells/ml. HIV patients included in this study
predominantly had a CD4+ T-cell count >200 cells/ml (83.2%, 332/
399). The majority had a CD4+ T-cell count ranging between 200 andgehiwot Referral Hospital
Chi-square df p-Value
n-ART (n = 200)
38 (49.4%) 0.02 1 0.880
7 (41.2%) 0.57 1 0.451
6 (26.1%) 5.64 1 0.018a
0 (0.0%) 5.09 1 0.024a
51 (25.5%)
22/399 (30.6%)
Table 3
Prevalence of enteric protozoan infection in relation to the clinical proﬁle of the study subjects; Felegehiwot Referral Hospital
Characteristics Status of infection, n (%) Total examined, n (%) Chi-square df p-Value
Infected Not infected
ART status
Pre-ART 71 (35.7) 128 (64.3) 199 (49.9) 1.59 1 0.208
On-ART 51 (25.5) 149 (74.5) 200 (50.1)
CD4+ T-cell count/ml
<200 34 (50.7) 33 (49.3) 67 (16.8) 23.10 2 0.000a
200–500 60 (25.4) 176 (74.6) 236 (59.1)
>500 17 (17.7) 79 (82.3) 96 (24.1)
Diarrhoeal status
Yes 31 (52.5) 28 (47.5) 59 (14.8) 21.08 1 0.000a
No 80 (23.5) 260 (76.5) 340 (85.2)
WHO stages of HIV infection
I 26 (33.8) 51 (66.2) 77 (19.3) 3.58 3 0.311
II 26 (22.6) 89 (77.4) 115 (28.8)
III 57 (29.1) 139 (70.9) 196 (49.1)
IV 2 (18.2) 9 (81.8) 11 (2.8)
ART, antiretroviral therapy; WHO, World Health Organization.
a Statistically signiﬁcant.
Figure 1. Status of enteric protozoan infection with reference to CD4+ T-cell count.
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236) were on ART and just under half (47.9%, 113/236) were pre-ART.
Approximately 24% (96/399) of the study subjects had a CD4+ T-cell
count >500 cells/ml, 49% (47/96) of whom were on ART and 51% (49/
96) pre-ART (Table 4). Sixty-seven patients (16.8%) had a CD4+ T-cell
count of <200 cells/ml, with 44.8% (30/67) on ART and 55.2% (37/67)
pre-ART (Figure 2).
3.4. Univariate analysis for the association of the prevalence of enteric
protozoan infection in relation to the clinical proﬁle and selected socio-
demographic factors
In the current study, based on univariate analysis, two factors
were found to be associated with intestinal protozoan infection
among HIV/AIDS patients: study subjects with a CD4+ T-cell count
<200 cells/ml and those with a positive diarrhoeal status had aTable 4
Univariate association between enteric protozoal infection and clinical proﬁles of stud
Characteristics Infected, n (%) Not infected, n (%
ART-status
Pre-ART 71 (35.7) 128 (64.3) 
On-ART 51 (25.5) 149 (74.5) 
CD4 T-cell count/ml
<200 34 (50.7) 33 (49.3) 
200–500 60 (25.4) 176 (74.6) 
>500 17 (17.7) 79 (82.3) 
Diarrhoeal status
Yes 31 (52.5) 28 (47.5) 
No 80 (23.5) 260 (76.5) 
OR, odds ratio; CI, conﬁdence interval; ART, antiretroviral therapy.
a Reference category.
b Statistically signiﬁcant.higher infection rate. The univariate analysis showed that patients
with a CD4+ T-cell count of <200 cells/ml were at increased risk of
enteric protozoan infection (odds ratio (OR) 4.79, 95% conﬁdence
interval (CI) 2.35–9.74, p = 0.000). Patients with a CD4+ T-cell
count <200 cell/ml were approximately ﬁve times more likely
to have an enteric protozoan infection than those with higher CD4+
T-cell counts (>500 cells/ml).
The prevalence of enteric protozoan infection among study
subjects with diarrhoea was 52.5%, whereas it was 47.5% in non-
diarrhoeic patients. There was an association between the
presence of enteric protozoan infections and diarrhoea (OR 3.60,
95% CI 2.04–6.38, p = 0.000). The odds of having an enteric
protozoan infection were 3.6 times higher in HIV-infected patients
with diarrhoea than in those who were non-diarrhoeic.
In the univariate analysis, CD4+ T-cell count and diarrhoeal
status were associated with the overall prevalence of enteric
protozoan infections. However, other socio-clinical, environmen-
tal, and sanitation variables had no signiﬁcant association with the
prevalence of enteric protozoan infections among people living
with HIV/AIDS, both pre-ART and on-ART subjects.
3.5. Univariate analysis for the association of the prevalence of
cryptosporidiosis and giardiasis with socio-clinical and sanitation
variables
The results showed a higher Cryptosporidium spp infection in
those patients who had a CD4+ T-cell count of <200 cells/ml. The
odds of a patient with a CD4+ T-cell count of <200 cells/ml being
infected with Cryptosporidium spp were about 15 times those of ay subjects
) Total examined, n (%) OR (95% CI)
199 (49.9) 0.75 (0.49–1.17)
200 (50.1) 1.00a
67 (16.8) 4.79 (2.35–9.74)b
236 (59.1) 1.58 (0.87–2.89)
96 (24.1) 1.00a
59 (14.8) 3.60 (2.04–6.38)b
340 (85.2) 1.00a
Figure 2. Evaluation of CD4+ T-cell count across ART status of study subjects.
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4.3–53.3, p = 0.000). The pattern of Cryptosporidium spp infection in
this study was highly associated among the diarrhoea status. The
odds of having cryptosporidiosis were 3.4 times higher in patients
with diarrhoea than in non-diarrhoeic individuals (OR 3.40, 95% CI
1.40–8.42, p = 0.008).
The present study, however, could not rule out access to a toilet
as a potential risk factor for infection with cryptosporidiosis in the
study population. Respondents who had no access to a toilet were
about four times more likely to harbour Cryptosporidium spp
compared to those respondents who had access to a toilet (OR 4.40,
95% CI 1.70–11.44, p = 0.002).
Giardiasis was signiﬁcantly associated with the location of
residence of the study participants. The odds of being infected with
G. lamblia were almost four times higher in patients who resided in
rural areas than in those who lived in urban areas (OR 3.76, 95% CI
1.04–10.08, p = 0.008). In the current study, the prevalence of
giardiasis was highly associated with the diarrhoea status. The
odds of the occurrence of giardiasis were 3.4 times higher in
patients with diarrhoea than in those without diarrhoea (OR 3.40,
95% CI 1.20–9.04, p = 0.021) (Table 5).
3.6. Multivariate analysis
Multivariate analysis using logistic regression conﬁrmed CD4+
T-cell count <200 cells/ml (adjusted OR (aOR) 3.62, 95% CI 1.73–
7.57, p = 0.001) and being diarrhoeic (aOR 2.74, 95% CI 1.5–5.02,
p = 0.001) as signiﬁcant risk factors for intestinal protozoan
infection among HIV/AIDS patients. However, when the inﬂuence
of other confounders was taken into account, the contribution of
ART status was no longer evident as a predictor for the prevalence
of enteric protozoan infection among study subjects.
With regard to Cryptosporidium spp infection, multiple logistic
regression analysis indicated that the variable CD4+ T-cell count
<200 cells/ml (aOR 7.8, 95% CI 2.73–22.33, p = 0.000) maintainedTable 5
Multivariate analysis of overall prevalence and cryptosporidiosis and giardiasis infectio
EPI Characteristics 
Overall infection ART-status Pre-ART vs. on-ARTa
CD4 status/ml <200 vs. >500a
Diarrhoea Yes vs. Noa
Cryptosporidium ART status Pre-ART vs. On-ARTa
CD4 count/ml <200 vs. >500a
Diarrhoea Yes vs. Noa
Residence Rural vs. Urbana
Toilet access No vs. Yesa
Giardiasis Residence Rural vs. Urbana
Diarrhoea Yes vs. Noa
EPI, enteric protozoan infection; cOR, crude odds ratio; aOR, adjusted odds ratio; CI, co
a Reference category.
b p-Value at aOR.
c Statistically signiﬁcant at cOR.
d Signiﬁcant at aOR.the signiﬁcant association with Cryptosporidium spp infection that
was identiﬁed previously in the univariate analysis. However, the
previously identiﬁed contributions of ART status, being diarrhoeic,
being a rural dweller, and having access to a toilet were no longer
apparent.
Furthermore, in the multiple logistic regression analysis,
location of residence (aOR 3.86, 95% CI 1.42–10.07, p = 0.008)
and diarrhoea (aOR 3.50, 95% CI 1.22–10.07, p = 0.020) retained
their positive association as predictors of giardiasis (Table 5).
4. Discussion
In this study, the prevalence of intestinal protozoan infections
among HIV-seropositive individuals with different immune status
was investigated. The examination of stool samples collected from
study subjects revealed an overall prevalence of 30.6% (122/399)
intestinal protozoan parasites; 71 cases (35.7%) were pre-ART
patients and 51 (25.5%) were on-ART patients (Table 2).
Due to down-regulation of the immune system, numerous
opportunistic infections with Cryptosporidium spp and I. belli occur
in individuals living with HIV/AIDS.15 Non-opportunistic parasites
such as E. histolytica/E. dispar and G. lamblia are also encountered
frequently in individuals living with HIV/AIDS, but they are not
considered opportunistic parasites.16
The ﬁndings of this study also showed an indiscriminate
prevalence of enteric protozoan infection among patients by age
category, sex, level of education, occupation, work status, and
other factors measured. Co-infections of coccidian parasites with
other non-opportunistic intestinal protozoa (E. histolytica/E. dispar
and G. lamblia) were encountered in this study. This is in
agreement with results from Nigeria.17
This study revealed that the prevalence of enteric coccidian
infection was higher among pre-ART patients than on-ART
patients. HIV subjects who had received ART had lower rates of
opportunistic infection compared to those who had not received
this therapy. This could be due to the fact that on-ART patients are
administered ARVs, in contrast to pre-ART patients, who are not
given ARVs. This is in agreement with a previous study that
showed the use of ART to be associated with parasite clearance
even when the patients responded poorly to ART in terms of the
CD4+ T-cell count.18 Furthermore, it has been suggested that HIV
protease inhibitors can act as antiparasitic drugs. For example, in
experimental studies, the drugs indinavir, saquinavir, and ritonavir
have been reported to have anti-Cryptosporidium spp effects both in
vitro and in vivo.19
In the present study, the overall prevalence of Cryptosporidium
spp infection among individuals living with HIV/AIDS was 5.8%,
which is similar to the prevalence reported previously inn across socio-clinical and environmental and sanitation factors
cOR (95% CI) aOR (95% CI) p-Value
0.75 (0.49–1.17) 0.76 (0.48–1.20) 0.233
4.79 (2.35–9.74)c 3.62 (1.73–7.57)d 0.001b
3.60 (2.04–6.38)c 2.74 (1.5–5.02)d 0.001b
0.33 (0.13–0.86) 0.871 (0.37–2.02) 0.747
15.16 (4.3–53.3)c 7.8 (2.73–22.33)d 0.000b
3.40 (1.40–8.42)c 1.05 (0.34–2.8) 0.927
2.21 (0.90–5.42) 1.27 (0.48–3.36) 0.630
4.40 (1.70–11.44)c 1.53 (0.51–4.57) 0.441
3.76 (1.40–10.09)c 3.86 (1.42–10.49)d 0.008b
3.40 (1.20–9.54)c 3.50 (1.22–10.07)d 0.020b
nﬁdence interval; ART, antiretroviral therapy.
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ART-naı¨ve HIV patients (8.5%) appear to be more vulnerable to
Cryptosporidium spp infection than patients on ART (3%). This
ﬁnding is in concordance with a relatively recent study undertaken
in Dessie Hospital among pre-and on-ART patients that reported
none of the on-ART patients to have a Cryptosporidium spp
infection.21
In the current study, with the exception of one case, the
prevalence of cryptosporidiosis was signiﬁcantly higher among
those with a CD4+ T-cell count of <200 cells/ml. This ﬁnding is
consistent with a previous report from Cameroon, which showed a
signiﬁcantly higher prevalence of cryptosporidial infection among
patients with a CD4+ T-cell count of <50 cells/ml.22 An association
of enteric coccidian parasites with lower CD4+ T-cell counts has
also been reported from India.6
I. belli is another enteric coccidian parasite that was detected
among HIV-positive persons. The prevalence of infection with I.
belli in the present study was 1.3%, which is lower than the 15.5%
reported from northwest Ethiopia.23 I. belli (1.3%) was detected
only in pre-ART study subjects; no such infection was detected in
patients on ART. I. belli was more common in patients with a CD4+
T-cell count of <200 cells/ml and the association between the CD4+
T-cell count and isosporiasis was signiﬁcant (p < 0.05). A similar
previous study from India reported a higher prevalence of I. belli in
patients with a CD4+ T-cell count of <200 cells/ml.24 The low
prevalence and variations of infection with isosporiasis could be
due to the wide use of anti-opportunistic infection medications,
ART, and geographic differences. Furthermore, it has been
suggested that co-trimoxazole prophylaxis given for other infec-
tions in AIDS cases and the low number of oocysts excreted are
possible explanations for the observed low prevalence of
isosporiasis.25
In the present study, the most prevalent parasite detected in
individuals living with HIV/AIDS was E. histolytica/E. dispar. The
overall prevalence of E. histolytica/E. dispar in this study accounted
for 19.3% (77/399). This is in agreement with previous results (20%)
among HIV/AIDS patients in Gambi Higher Clinic, Bahir Dar,
Ethiopia.22 Furthermore, the present ﬁnding is comparable with
the prevalences of 25.3%, 16.8%, and 15% reported from Mexico,
Malaysia, and India, respectively.26–28 The present ﬁnding,
however, was relatively higher (19.3%) compared to the prevalence
rate of 10.3% observed among individuals living with HIV/AIDS in a
teaching hospital in Jimma, southwest Ethiopia.29
The prevalence of giardiasis in the present study was 4.3%. This
ﬁnding is in concordance with data from Jimma Teaching Hospital,
southwest Ethiopia (3.8%).29 Findings from the current study
showed that infection with giardiasis was considerably lower
when compared to other studies carried out among individuals
living with HIV/AIDS. A higher infection rate, 16%, was reported
in Ethiopia in selected ART centres in Adama, Afar, and Dire-
Dawa.11 A higher rate of infection has also been reported from
Hawassa Teaching and Referral Hospital, southern Ethiopia
(11.2%).20 A considerably higher prevalence of giardiasis compared
to the present ﬁnding has also been observed in previous works
performed in other tropical regions, such as 14.9% from a study
conducted at a mission hospital in tropical West Africa30 and 8%
from India.31
Mixed infection was the other observation found in the present
study. The combined prevalence of both double and triple infection
accounted for 2.3%. The multiple infection rate in the current study
was, however, relatively lower than that reported previously in
Ethiopia (27.2%).20
In the current study, 14.8% (59/399) of study subjects were
identiﬁed with diarrhoea. On multivariate analysis, diarrhoea was
found to be more frequent among HIV/AIDS study subjects with
cryptosporidiosis, isosporiasis, amoebiasis, and giardiasis comparedto those patients without diarrhoea. This association is in agreement
with other earlier reports that indicated an association between the
occurrence of diarrhoea and enteric protozoa infections among
individuals living with HIV/AIDS. This association has been reported
in different parts of tropical countries.30,32
This study revealed the CD4+ T-cell status to be one of the
clinical determinants of enteric protozoan infection in patients
with a CD4+ T-cell count of <200 cells/ml. The infection was
considerably higher in patients with a CD4+ T-cell count of <200
cells/ml. After adjusting for confounders, HIV-infected patients
who had a CD4+ T-cell count of <200 cell/ml were at about four
times greater risk (aOR 3.62, 95% CI 1.73–7.57, p = 0.001) of having
an enteric protozoan infection compared to those who had a CD4+
T-cell count >500 cells/ml. The association between the CD4+
T-cell count and intestinal protozoa infection has also been
reported in previous studies from Ethiopia, India, Malaysia, and
Senegal.20,27,28,33
Most of the socio-demographic features in the present study
were not statistically signiﬁcant as predictors of the manifestations
of enteric protozoan infection among individuals living with HIV/
AIDS. Demographic variables such as age, sex, location of residence,
marital status, work status, monthly income, and level of education
were not implicated as determinants of the occurrence of enteric
protozoal infection among the study subjects.
In conclusion, the overall prevalence of enteric protozoan
infection in individuals living with HIV/AIDS was 30.6%. E.
histolytica infection was the most prevalent, followed by Crypto-
sporidium spp, G. lamblia, and I. belli infections. The rate of infection
with Cryptosporidium spp and Isospora belli was found to be higher
in pre-ART patients than in on-ART patients.
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